Abstract
Purpose: To describe a case of full thickness macular hole after intravitreal brolucizumab injection in neovascular age-related macular degeneration, which has not been reported to date. Case description: A 65-year-old male patient received brolucizumab intravitreal injection therapy for neovascular macular degeneration of the right eye. He received multiple intravitreal anti-VEGF injections on a pro re nata regimen and developed a full thickness macular hole. Outcome: Surgical treatment was performed with pars plana vitrectomy of the right eye. Full thickness macular hole was successfully treated. Conclusion: Although a full thickness macular hole following intravitreal brolucizumab injection is an uncommon complication, it requires caution.
| Original language | English |
|---|---|
| Pages (from-to) | NP16-NP19 |
| Journal | European Journal of Ophthalmology |
| Volume | 35 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 2025 |
Bibliographical note
Publisher Copyright:© The Author(s) 2024.
Keywords
- Macular hole
- anti-VEGF
- brolucizumab
Fingerprint
Dive into the research topics of 'Full thickness macular hole after intravitreal brolucizumab injection in neovascular age-related macular degeneration'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver